Compare with Penghua CNI Vaccine and Biotechnology ETF Units
Key stats
Fund info
Home page
Inception date
Feb 22, 2023
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
Penghua Fund Management Co., Ltd.
ISIN
CNE100005WG5
FIGI
BBG01F5SBDC4
Identifiers
ISIN CNE100005WG5
Tightly track the target index, and pursue the minimization of tracking deviation and tracking error. The Fund strives to control the daily average tracking deviation within 0.2% , and the annual tracking error within 2% .
Classification
What's in the fund
Exposure type
Health Technology
Breakdown by region
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
159657 trades at 0.594 CNY today, its price has risen 1.23% in the past 24 hours. Track more dynamics on 159657 price chart.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
159657 invests in stocks. See more details in our Profile section.
159657 expense ratio is 0.60%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, 159657 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 159657 technical analysis shows the buy rating and its 1-week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 159657 shows the sell signal. See more of 159657 technicals for a more comprehensive analysis.
Today, 159657 technical analysis shows the buy rating and its 1-week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 159657 shows the sell signal. See more of 159657 technicals for a more comprehensive analysis.
No, 159657 doesn't pay dividends to its holders.
159657 trades at a premium (0.34%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
159657 shares are issued by Penghua Fund Management Co., Ltd.
159657 follows the CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Feb 22, 2023.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.